Inhaled cannabis reduces self-reported headache and migraine severity by approximately 50%, based on a medical cannabis app study. However, its effectiveness diminish and patients appear to use larger doses across time, suggesting tolerance to these effects may develop with continued use.

Inhaled cannabis reduces self-reported headache and migraine severity by approximately 50%, based on a medical cannabis app study. However, its effectiveness diminish and patients appear to use larger doses across time, suggesting tolerance to these effects may develop with continued use.: https://ift.tt/2D0AVir Read more... https://ift.tt/2OCHInG